Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Deciphera Pharmaceuticals LLC stock
Learn how to easily invest in Deciphera Pharmaceuticals LLC stock.
Deciphera Pharmaceuticals LLC is a drug manufacturers-specialty & generic business based in the US. Deciphera Pharmaceuticals LLC shares (DCPH) are listed on the NASDAQ and all prices are listed in US Dollars. Deciphera Pharmaceuticals LLC employs 280 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Deciphera Pharmaceuticals LLC
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – DCPH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Deciphera Pharmaceuticals LLC stock price (NASDAQ: DCPH)Use our graph to track the performance of DCPH stocks over time.
Deciphera Pharmaceuticals LLC shares at a glance
|Latest market close||$13.26|
|52-week range||$6.51 - $38.91|
|50-day moving average||$10.99|
|200-day moving average||$14.42|
|Wall St. target price||$10.78|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-4.90|
Buy Deciphera Pharmaceuticals LLC shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Deciphera Pharmaceuticals LLC stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Deciphera Pharmaceuticals LLC price performance over time
|1 week (2022-06-24)||-3.42%|
|1 month (2022-06-02)||19.57%|
|3 months (2022-03-29)||N/A|
|6 months (2021-12-31)||35.72%|
|1 year (2021-07-02)||-63.62%|
|2 years (2020-07-02)||-76.62%|
|3 years (2019-07-02)||23.09|
|5 years (2017-06-28)||N/A|
Deciphera Pharmaceuticals LLC financials
|Revenue TTM||$100.2 million|
|Gross profit TTM||$-141,624,000|
|Return on assets TTM||-33.05%|
|Return on equity TTM||-73.73%|
|Market capitalisation||$909.2 million|
TTM: trailing 12 months
Deciphera Pharmaceuticals LLC share dividends
We're not expecting Deciphera Pharmaceuticals LLC to pay a dividend over the next 12 months.
Deciphera Pharmaceuticals LLC share price volatility
Over the last 12 months, Deciphera Pharmaceuticals LLC's shares have ranged in value from as little as $6.51 up to $38.91. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Deciphera Pharmaceuticals LLC's is 1.3984. This would suggest that Deciphera Pharmaceuticals LLC's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Deciphera Pharmaceuticals LLC overview
Deciphera Pharmaceuticals, Inc. , a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts. .
Deciphera Pharmaceuticals LLC in the news
Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer
Deciphera (DCPH) Up More Than 30% in Past 3 Months: Here's Why
Deciphera Pharmaceuticals, Inc. (DCPH) Up 4.3% Since Last Earnings Report: Can It Continue?
Frequently asked questionsWhat percentage of Deciphera Pharmaceuticals LLC is owned by insiders or institutions?
Currently 27.902% of Deciphera Pharmaceuticals LLC shares are held by insiders and 69.225% by institutions. How many people work for Deciphera Pharmaceuticals LLC?
Latest data suggests 280 work at Deciphera Pharmaceuticals LLC. When does the fiscal year end for Deciphera Pharmaceuticals LLC?
Deciphera Pharmaceuticals LLC's fiscal year ends in December. Where is Deciphera Pharmaceuticals LLC based?
Deciphera Pharmaceuticals LLC's address is: 200 Smith Street, Waltham, MA, United States, 02451 What is Deciphera Pharmaceuticals LLC's ISIN number?
Deciphera Pharmaceuticals LLC's international securities identification number is: US24344T1016 What is Deciphera Pharmaceuticals LLC's CUSIP number?
Deciphera Pharmaceuticals LLC's Committee on Uniform Securities Identification Procedures number is: 24344T101
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert